Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04770207
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2020-12-02
Brief Title:
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Organization:
Second Affiliated Hospital of Guangzhou Medical University
Study Overview
Official Title:
Intra-tumor Injection of Drug-eluting Microspheres Loading With Chemodrug Plus Checkpoint Inhibitors andor IL2 for Treatment of Advanced Solid Tumors
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug andor protein drugs into advanced solid tumors
Detailed Description:
Drug-eluting microspheres such as DC-beads will be loaded with IL2 PD1PDL1CTLA4 antibody or and VEGFVEGFR antibody with or without doxorubicinidarubicin for various time and injected into tumors under CT guidance Side effects and treatment efficacy after injection of drug-eluting microspheres into malignant tumors will be assessed according to RICEST11 standard
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None